UNSPSC 41142034: Phosphohexose isomerase test system

In this classification, Phosphohexose isomerase test system connotes a device used to measure Phosphohexose isomerase levels. US FDA regulates Phosphohexose isomerase test system under 21 CFR 862.1570 and under FDA product code JNE.

UNSPSC 41142034 Phosphohexose isomerase test system is a Commodity code under which state and local governments procure diagnostic reagents and test kits for forensic drug analysis, clinical toxicology screening, and infectious disease testing — including Direct ELISA kits for substance detection, DNA screening kits, and certified reference materials for method validation. Recent solicitations show state forensic laboratories, public health agencies, and crime analysis divisions buying immunoassay reagents, drug standards with documented purity and ISO accreditation, and molecular diagnostic equipment to support evidentiary analysis and quality assurance in laboratory operations. The issuing bodies span state law enforcement agencies (Texas Department of Public Safety, Texas Department of Criminal Justice), state health departments (Texas Health and Human Services Commission, Department of State Health Services, Florida Department of Law Enforcement), and county forensic laboratories (Pinellas County, Florida). These agencies procure both consumables and equipment on a recurring basis to maintain forensic and toxicology testing capacity.

Recent activity concentrates in Texas and Florida. Representative opportunities include the Texas Department of Public Safety's July 2026 IFB 405-26R0008445A for Direct ELISA testing kits spanning 12 substance-analysis line items (due July 23, 2026), Pinellas County's April 2026 Invitation to Quote for 131 line items of certified drug reference standards with ISO/IEC 17025 accreditation (due April 23, 2026, funded through the Paul Coverdell Forensic Sciences Improvement Act with $49,034.00 designated for equipment and supplies), and Texas Health and Human Services Commission's IFB HHS0016902v2 for QIAxcel and QIAamp DNA screening kits (due January 29, 2026, with historical spend guidance of $25,050 to $30,000 for fiscal year 2025). The Illinois Department of Financial and Professional Regulation also posted a May 2026 joint purchase master contract for RAMP mosquito testing equipment targeting multistate agency distribution. Vendors responding to forensic and toxicology opportunities must comply with state-specific HUB subcontracting plans, financial documentation requirements, and federal accreditation standards.